The relationship between gut microbiota and Alzheimer's  disorder

Tiankai Li

doi:10.54254/2753-8818/63/20241649

Research Article

Open access

Published on 22 November 2024

Download pdf

Li,T. (2024). The relationship between gut microbiota and Alzheimer's disorder. Theoretical and Natural Science,63,95-99.

Export citation

The relationship between gut microbiota and Alzheimer's disorder

Tiankai Li *^,1,

¹ the second high school attached to Beijing Normal University

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2753-8818/63/20241649

Abstract

The pathology of Alzheimer's disorder: neuron degeneration is the main cause of Alzheimer's disorder. Several ways will stimulate the degeneration of cells. The links between gut microbiota and Alzheimer's disorder consist of three major pathways: the vagus nerve, blood circulation, and release of chemical molecules. This paper discusses not only the pathology of Alzheimer’s disorder but also explores the connections between gut microbiota and Alzheimer’s disorder, as well as potential treatments based on gut microbiota. Probiotics are mainly discussed in this paper to present possible treatments for Alzheimer's disorder. To conclude, this paper mainly discusses the link between Alzheimer’s disorder and gut microbiota. Moreover, the conclusion highlights unresolved issues and unknown aspects of the interaction between Alzheimer’s and gut microbiota, urging further research and increased attention from scientists.

Keywords

gut microbiota, Alzheimer's, the relationship between gut microbiota and Alzheimer's.

View pdf

References

[1]. Khan S, Barve KH, Kumar MS. Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease. Curr Neuropharmacol. 2020; 18(11): 1106-1125. doi: 10.2174/1570159X18666200528142429. PMID: 32484110; PMCID: PMC7709159.

[2]. Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Alzheimer's disease. Lancet. 2016 Jul 30; 388(10043): 505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24. PMID: 26921134.

[3]. Barage SH, Sonawane KD. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease. Neuropeptides. 2015 Aug; 52: 1-18. doi: 10.1016/j.npep.2015.06.008. Epub 2015 Jul 2. PMID: 26149638.

[4]. Crews L, Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet. 2010 Apr 15; 19(R1): R12-20. doi: 10.1093/hmg/ddq160. Epub 2010 Apr 22. PMID: 20413653; PMCID: PMC2875049.

[5]. Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer's disease. Nat Immunol. 2015 Mar; 16(3):229-36. doi: 10.1038/ni.3102. PMID: 25689443.

[6]. Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019 Feb; 76(3): 473-493. doi: 10.1007/s00018-018-2943-4. Epub 2018 Oct 13. PMID: 30317530; PMCID: PMC11105460.

[7]. Dinan TG, Cryan JF. The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterol Clin North Am. 2017 Mar; 46(1): 77-89. doi: 10.1016/j.gtc.2016.09.007. Epub 2017 Jan 4. PMID: 28164854.

[8]. Angelucci F, Cechova K, Amlerova J, Hort J. Antibiotics, gut microbiota, and Alzheimer's disease. J Neuroinflammation. 2019 May 22; 16(1): 108. doi: 10.1186/s12974-019-1494-4. PMID: 31118068; PMCID: PMC6530014.

[9]. Logsdon AF, Erickson MA, Rhea EM, Salameh TS, Banks WA. Gut reactions: How the blood-brain barrier connects the microbiome and the brain. Exp Biol Med (Maywood). 2018 Jan; 243(2): 159-165. doi: 10.1177/1535370217743766. Epub 2017 Nov 23. PMID: 29169241; PMCID: PMC5788145.

[10]. Galland L. The gut microbiome and the brain. J Med Food. 2014 Dec; 17(12): 1261-72. doi: 10.1089/jmf.2014.7000. PMID: 25402818; PMCID: PMC4259177.

[11]. Alam R, Abdolmaleky HM, Zhou JR. Microbiome, inflammation, epigenetic alterations, and mental diseases. Am J Med Genet B Neuropsychiatr Genet. 2017 Sep; 174(6): 651-660. doi: 10.1002/ajmg.b.32567. Epub 2017 Jul 10. PMID: 28691768; PMCID: PMC9586840.

[12]. Liu S, Gao J, Zhu M, Liu K, Zhang HL. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment. Mol Neurobiol. 2020 Dec; 57(12): 5026-5043. doi: 10.1007/s12035-020-02073-3. Epub 2020 Aug 23. PMID: 32829453; PMCID: PMC7541367.

[13]. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017 Aug; 14(8): 491-502. doi: 10.1038/nrgastro.2017.75. Epub 2017 Jun 14. PMID: 28611480.

[14]. Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019 May; 25(5): 716-729. doi: 10.1038/s41591-019-0439-x. Epub 2019 May 6. PMID: 31061539.

[15]. Yang X, Yu D, Xue L, Li H, Du J. Probiotics modulate the microbiota-gut-brain axis and improve memory deficits in aged SAMP8 mice. Acta Pharm Sin B. 2020 Mar; 10(3): 475-487. doi: 10.1016/j.apsb.2019.07.001. Epub 2019 Jul 7. PMID: 32140393; PMCID: PMC7049608.

[16]. Leblhuber F, Egger M, Schuetz B, Fuchs D. Commentary: Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial. Front Aging Neurosci. 2018 Mar 6; 10:54. doi: 10.3389/fnagi.2018.00054. PMID: 29559906; PMCID: PMC5845584.

Cite this article

Li,T. (2024). The relationship between gut microbiota and Alzheimer's disorder. Theoretical and Natural Science,63,95-99.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science

Conference website: https://2024.icbiomed.org/

ISBN：978-1-83558-729-4(Print) / 978-1-83558-730-0(Online)

Conference date: 25 October 2024

Editor：Alan Wang

Series: Theoretical and Natural Science

Volume number: Vol.63

ISSN：2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).